[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB0820526D0 - Compounds having crth2 antagonist activity - Google Patents

Compounds having crth2 antagonist activity

Info

Publication number
GB0820526D0
GB0820526D0 GB0820526A GB0820526A GB0820526D0 GB 0820526 D0 GB0820526 D0 GB 0820526D0 GB 0820526 A GB0820526 A GB 0820526A GB 0820526 A GB0820526 A GB 0820526A GB 0820526 D0 GB0820526 D0 GB 0820526D0
Authority
GB
United Kingdom
Prior art keywords
compounds
antagonist activity
crth2 antagonist
crth2
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0820526A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxagen Ltd
Original Assignee
Oxagen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxagen Ltd filed Critical Oxagen Ltd
Priority to GB0820526A priority Critical patent/GB0820526D0/en
Publication of GB0820526D0 publication Critical patent/GB0820526D0/en
Priority to BRPI0906786-8A priority patent/BRPI0906786B1/en
Priority to DK09702598.5T priority patent/DK2250161T3/en
Priority to RU2010129027/04A priority patent/RU2503672C2/en
Priority to AU2009204700A priority patent/AU2009204700B2/en
Priority to SI200930822T priority patent/SI2250161T1/en
Priority to PCT/GB2009/000142 priority patent/WO2009090414A1/en
Priority to CN200980103456.8A priority patent/CN101932571B/en
Priority to RS20140016A priority patent/RS53142B/en
Priority to MX2010007833A priority patent/MX2010007833A/en
Priority to EP09702598.5A priority patent/EP2250161B1/en
Priority to MYPI2010003390A priority patent/MY155133A/en
Priority to ES09702598.5T priority patent/ES2442717T3/en
Priority to JP2010542688A priority patent/JP2011509988A/en
Priority to KR1020107017661A priority patent/KR101644170B1/en
Priority to PT97025985T priority patent/PT2250161E/en
Priority to PL09702598T priority patent/PL2250161T3/en
Priority to CA2712017A priority patent/CA2712017C/en
Priority to NZ587251A priority patent/NZ587251A/en
Priority to US12/356,822 priority patent/US20090186923A1/en
Priority to US12/625,497 priority patent/US7750027B2/en
Priority to US12/828,800 priority patent/US7919512B2/en
Priority to IL206959A priority patent/IL206959A/en
Priority to ZA2010/05799A priority patent/ZA201005799B/en
Priority to MA33081A priority patent/MA32075B1/en
Priority to HK10111663.1A priority patent/HK1145175A1/en
Priority to US13/014,314 priority patent/US8536158B2/en
Priority to US13/017,860 priority patent/US8563536B2/en
Priority to US14/047,469 priority patent/US8980927B2/en
Priority to CY20141100031T priority patent/CY1114748T1/en
Priority to HRP20140045AT priority patent/HRP20140045T1/en
Priority to JP2014095946A priority patent/JP5855162B2/en
Priority to US14/658,863 priority patent/US20150246030A1/en
Ceased legal-status Critical Current

Links

GB0820526A 2008-01-18 2008-11-10 Compounds having crth2 antagonist activity Ceased GB0820526D0 (en)

Priority Applications (33)

Application Number Priority Date Filing Date Title
GB0820526A GB0820526D0 (en) 2008-11-10 2008-11-10 Compounds having crth2 antagonist activity
RS20140016A RS53142B (en) 2008-01-18 2009-01-19 Compounds having crth2 antagonist activity
PL09702598T PL2250161T3 (en) 2008-01-18 2009-01-19 Compounds having crth2 antagonist activity
NZ587251A NZ587251A (en) 2008-01-18 2009-01-19 Indole derivatives having CRTH2 antagonist activity
RU2010129027/04A RU2503672C2 (en) 2008-01-18 2009-01-19 Compounds having crth2 antagonist activity
CA2712017A CA2712017C (en) 2008-01-18 2009-01-19 Compounds having crth2 antagonist activity
SI200930822T SI2250161T1 (en) 2008-01-18 2009-01-19 Compounds having crth2 antagonist activity
PCT/GB2009/000142 WO2009090414A1 (en) 2008-01-18 2009-01-19 Compounds having crth2 antagonist activity
CN200980103456.8A CN101932571B (en) 2008-01-18 2009-01-19 Compounds having CRTH2 antagonist activity
DK09702598.5T DK2250161T3 (en) 2008-01-18 2009-01-19 Compounds with CRTH2 antagonist activity
MX2010007833A MX2010007833A (en) 2008-01-18 2009-01-19 Compounds having crth2 antagonist activity.
EP09702598.5A EP2250161B1 (en) 2008-01-18 2009-01-19 Compounds having crth2 antagonist activity
MYPI2010003390A MY155133A (en) 2008-01-18 2009-01-19 Compounds having crth2 antagonist activity
ES09702598.5T ES2442717T3 (en) 2008-01-18 2009-01-19 Compounds that have CRTH2 antagonistic activity
JP2010542688A JP2011509988A (en) 2008-01-18 2009-01-19 Compound having CRTH2 antagonist activity
KR1020107017661A KR101644170B1 (en) 2008-01-18 2009-01-19 Compounds having crth2 antagonist activity
PT97025985T PT2250161E (en) 2008-01-18 2009-01-19 Compounds having crth2 antagonist activity
BRPI0906786-8A BRPI0906786B1 (en) 2008-01-18 2009-01-19 COMPOUND, PROCESS FOR THE PREPARATION OF A COMPOUND, PHARMACEUTICAL COMPOSITION, PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION, AND, PRODUCT
AU2009204700A AU2009204700B2 (en) 2008-01-18 2009-01-19 Compounds having CRTH2 antagonist activity
US12/356,822 US20090186923A1 (en) 2008-01-18 2009-01-21 Compounds Having CRTH2 Antagonist Activity
US12/625,497 US7750027B2 (en) 2008-01-18 2009-11-24 Compounds having CRTH2 antagonist activity
US12/828,800 US7919512B2 (en) 2008-01-18 2010-07-01 Compounds having CRTH2 antagonist activity
IL206959A IL206959A (en) 2008-01-18 2010-07-12 [({2-sulfonylpyridin-3-yl}methyl)2-methylindol-1-yl]- ethanoates and use thereof in preparing a medicament
MA33081A MA32075B1 (en) 2008-01-18 2010-08-13 Compounds having an antagonistic activity of crth2
ZA2010/05799A ZA201005799B (en) 2008-01-18 2010-08-13 Compounds having crth2 antagonist activity
HK10111663.1A HK1145175A1 (en) 2008-01-18 2010-12-14 Compounds having crth2 antagonist activity
US13/014,314 US8536158B2 (en) 2008-01-18 2011-01-26 Compounds having CRTH2 antagonist activity
US13/017,860 US8563536B2 (en) 2008-01-18 2011-01-31 Compounds having CRTH2 antagonist activity
US14/047,469 US8980927B2 (en) 2008-01-18 2013-10-07 Compounds having CRTH2 antagonist activity
CY20141100031T CY1114748T1 (en) 2008-01-18 2014-01-15 COMPOUNDS WHICH HAVE CRTH2 COMPETITIVE ACTIVITY
HRP20140045AT HRP20140045T1 (en) 2008-01-18 2014-01-15 Compounds having crth2 antagonist activity
JP2014095946A JP5855162B2 (en) 2008-01-18 2014-05-07 Compound having CRTH2 antagonist activity
US14/658,863 US20150246030A1 (en) 2008-01-18 2015-03-16 Compounds Having CRTH2 Antagonist Activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0820526A GB0820526D0 (en) 2008-11-10 2008-11-10 Compounds having crth2 antagonist activity

Publications (1)

Publication Number Publication Date
GB0820526D0 true GB0820526D0 (en) 2008-12-17

Family

ID=40139659

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0820526A Ceased GB0820526D0 (en) 2008-01-18 2008-11-10 Compounds having crth2 antagonist activity

Country Status (1)

Country Link
GB (1) GB0820526D0 (en)

Similar Documents

Publication Publication Date Title
ZA201005799B (en) Compounds having crth2 antagonist activity
IL196640A0 (en) Compounds having crth2 antagonist activity
ZA200807913B (en) Salts with CRTH2 antagonist activity
GB0722216D0 (en) Use of crth2 antagonist compounds
GB0722203D0 (en) Use of CRTH2 antagonist compounds
EP2627178A4 (en) Quinazolinone-type compounds as crth2 antagonists
GB0810902D0 (en) New compounds
GB0800035D0 (en) Compounds
EP2518041A4 (en) Benzyl compound
EP2379510A4 (en) Quinazolinone compounds
IL210344A0 (en) New compounds
ZA201104777B (en) Substituted quinazoline compounds
GB0800367D0 (en) Compounds
ZA200900393B (en) Compounds having CRTH2 antagonist activity
HK1145675A1 (en) Quinazoline compounds
GB0801674D0 (en) Compounds having CRTH2 antagonist activity
ZA201101390B (en) Self cleaning arrangement
HU0800478D0 (en) New compounds
GB0818365D0 (en) Quinoline compounds
GB0801220D0 (en) Compounds
GB0800874D0 (en) Compounds having CRTH2 antagonist activity
GB0801131D0 (en) Compounds having CRTH2 antagonist activity
GB0820526D0 (en) Compounds having crth2 antagonist activity
GB0801672D0 (en) Compounds having crth2 antagonist activity
GB0801671D0 (en) Compounds having crth2 antagonist activity

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)